Joseph Califano UCSD Cancer
@califanomd
Physician in Chief Moores Cancer Center, University of California, San Diego. Surgeon. Researcher. Note: All opinions are my own
ID: 1057002694961819651
29-10-2018 20:14:15
92 Tweet
572 Followers
136 Following
We wanted to recognize Co-Director of the Gleiberman Head & Neck Cancer Center, Dr. Loren Mell for his appointment to the National Cancer Institute (NCI). Mell will serve as the Co-Chair of the Head and Neck Cancer Steering Committee National Cancer Institute UC San Diego Health Congrats Dr. Loren K. Mell
Enjoyed publishing in the Journal of the @NCCN re: A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation. Read more: pubmed.ncbi.nlm.nih.gov/34450596/
One of our grateful patient stories is now airing across the nation. Please find the attached story regarding the impact that her journey has made as we continue to serve those in the field of head & neck oncology. @ivanhoenews UC San Diego News UC San Diego Health ivanhoe.com/medical-breakt…
Congratulations Silvio from your lab team, for receiving your diploma for your 2019 induction into the National Academy of Medicine! National Academy of Medicine UC San Diego UC San Diego Health Moores Cancer Center UC San Diego Health Sciences Department of Pharmacology, UCSD
Surfer Researcher Surgeon and now UC San Diego Health Moores Cancer Center Moores Cancer Center Director Dr. Joe Califano - Joseph Califano UCSD Cancer #DeliveringDiscoveries
My new boss surfs. And is a surgeon. And researches head and neck cancer. He’s pretty awesome. Congrats Joseph Califano UCSD Cancer on the role- and making the cover of The Cancer Letter.
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect- excited to explore this strategy in #HNSCC Nature Cancer Joseph Califano UCSD Cancer Ezra Cohen Rom Leidner GutkindLab Robert S-K nature.com/articles/s4301…
The UC San Diego Health Moores Cancer Center team made 3 of the "23 oncology firsts" for 2022! #1 - preclinical model of appendiceal cancer #5 - advanced prostate cancer tx with Pluvicto #23 - employing high-intensity ultrasound as a minimally invasive prostate cancer treatment beckershospitalreview.com/oncology/23-on…
S1801. Practice changing data in high risk clinical stage 3 melanoma showing clear benefit in neoadjuavnt immunotherapy. Congratulations Sapna Patel SWOG Cancer Research Network on publishing the results in NEJM. nejm.org/doi/full/10.10…